International Journal of Biomedical Science and Travel Medicine,
Год журнала:
2024,
Номер
1(1), С. 7 - 11
Опубликована: Март 30, 2024
Background
The
global
mortality
rate
for
coronavirus
disease-2019
(COVID-19)
continues
to
climb.
study
goal
is
provide
a
proper
equation
predict
in
COVID-19
patients
based
on
medical
history,
and
laboratory
examination
Methods
This
was
case-control
study.
Patients
with
confirmed
case
taken
physical,
examination.
CBC
D-Dimer
were
checked
when
admitted
the
hospital.
Statistical
analysis
that
use
include
Chi-Square
or
Fisher’s
test
as
comparative
study,
risk
estimate
odds
ratio,
logistic
regression
formulated
equation.
Results
Ninety-six
gathered
at
end
of
grouped
survival
care
which
life
death
dependent
variable.
We
also
several
parameter
like
geriatric
age,
comorbidities,
symptoms
(fever,
cough,
anosmia,
cold,
dysphagia,
shortness
breath),
anemia,
leukocytosis/leukopenia,
thrombocytopenia,
elevated
D-Dimer,
pneumonia,
independent
variables.
Geriatric,
fever,
breath,
leukocytosis/leucopenia,
lymphopenia,
had
significant
differences
p
<
0.05.
Odds
ratio
95%CI
these
parameters
3.02
(1.11-8.20),
4.07
(1.35-12.27),
3.57
(0.96-13.23),
5.04
(1.08-23.34),
4.75
(1.02-22.02),
3.26
(1.15-9.25),
6.40
(2.19-18.63),
3.16
(0.97-10.30),
0.70
(0.61-0.81),
respectively.
Multivariate
using
this
result
calculated
we
able
make
probability
equation,
=
1/(1+e-y),
e
=2.7,
y
-
24.99
+
1.621(comorbidities)
1.944(cough)
1.643(leukocytosis/leukopenia)
1.397(anemia)
20.625(elevated
D-Dimer).
ROC
confirm
predicted
AUC
0.88
Conclusion
simple
enough
be
used
tool
clinician
patients.
If
assume
example
patient
comorbidities
cough
symptoms,
level
result,
then
90.25%
outcome.
up
our
excellent
discrimination
between
International Journal of ADVANCED AND APPLIED SCIENCES,
Год журнала:
2025,
Номер
12(1), С. 112 - 124
Опубликована: Янв. 1, 2025
The
presence
of
missing
data
in
machine
learning
(ML)
datasets
remains
a
major
challenge
building
reliable
models.
This
study
explores
various
strategies
to
handle
and
provides
framework
evaluate
their
effectiveness.
research
focuses
on
commonly
used
techniques
such
as
zero-filling,
deletion,
imputation
methods,
including
mean,
median,
mode,
regression,
k-nearest
neighbors
(KNN),
flagging.
To
assess
these
detailed
evaluation
is
proposed,
considering
factors
completeness,
model
performance,
stability,
bias,
variance,
robustness
new
data,
computational
efficiency,
domain-specific
needs.
comprehensive
approach
allows
for
thorough
comparison
helping
identify
the
most
suitable
technique
specific
tasks.
findings
highlight
importance
unique
features
dataset
goals
analysis
when
choosing
method.
While
basic
like
deletion
zero-filling
may
be
effective
some
cases,
advanced
methods
often
preserve
quality
improve
accuracy.
By
applying
proposed
criteria,
researchers
practitioners
can
make
better
decisions
handling
leading
more
accurate,
reliable,
adaptable
ML
Diagnostics,
Год журнала:
2024,
Номер
14(13), С. 1456 - 1456
Опубликована: Июль 8, 2024
The
advent
of
artificial
intelligence
(AI)
is
revolutionizing
medicine,
particularly
radiology.
With
the
development
newer
models,
AI
applications
are
demonstrating
improved
performance
and
versatile
utility
in
clinical
setting.
Thoracic
imaging
an
area
profound
interest,
given
prevalence
chest
significant
health
implications
thoracic
diseases.
This
review
aims
to
highlight
promising
within
imaging.
It
examines
role
AI,
including
its
contributions
improving
diagnostic
evaluation
interpretation,
enhancing
workflow,
aiding
invasive
procedures.
Next,
it
further
highlights
current
challenges
limitations
faced
by
such
as
necessity
'big
data',
ethical
legal
considerations,
bias
representation.
Lastly,
explores
potential
directions
for
application
Journal of Personalized Medicine,
Год журнала:
2023,
Номер
14(1), С. 53 - 53
Опубликована: Дек. 29, 2023
Precision
medicine
(PM),
through
the
integration
of
omics
and
environmental
data,
aims
to
provide
a
more
precise
prevention,
diagnosis,
treatment
disease.
Currently,
PM
is
one
emerging
approaches
in
modern
healthcare
public
health,
with
wide
implications
for
health
care
delivery,
policy
making
formulation,
entrepreneurial
endeavors.
In
spite
its
growing
popularity
buzz
surrounding
it,
still
nascent
phase,
facing
considerable
challenges
that
need
be
addressed
resolved
it
attain
acclaim
which
strives.
this
article,
we
discuss
some
current
methodological
pitfalls
PM,
including
use
big
perspective
on
how
these
can
overcome
by
bringing
closer
evidence-based
(EBM).
Furthermore,
maximize
potential
present
real-world
illustrations
EBM
principles
integrated
into
approach.
BMC Pulmonary Medicine,
Год журнала:
2024,
Номер
24(1)
Опубликована: Янв. 10, 2024
Abstract
Background
Despite
global
efforts
to
control
the
COVID-19
pandemic,
emergence
of
new
viral
strains
continues
pose
a
significant
threat.
Accurate
patient
stratification,
optimized
resource
allocation,
and
appropriate
treatment
are
crucial
in
managing
cases.
To
address
this,
simple
accurate
prognostic
tool
capable
rapidly
identifying
individuals
at
high
risk
mortality
is
urgently
needed.
Early
prognosis
facilitates
predicting
outcomes
enables
effective
management.
The
aim
this
study
was
develop
an
early
predictive
model
for
assessing
hospitalized
patients,
utilizing
baseline
clinical
factors.
Methods
We
conducted
descriptive
cross-sectional
involving
cohort
375
patients
admitted
treated
Patient
Treatment
Center
Military
Hospital
175
from
October
2021
December
2022.
Results
Among
246
129
were
categorized
into
survival
groups,
respectively.
Our
findings
revealed
six
factors
that
demonstrated
independent
value
patients.
These
included
age
greater
than
50
years,
presence
multiple
underlying
diseases,
dyspnea,
acute
confusion,
saturation
peripheral
oxygen
below
94%,
demand
exceeding
5
L
per
minute.
integrated
these
scale
(MH175),
demonstrating
discriminatory
ability
with
area
under
curve
(AUC)
0.87.
optimal
cutoff
using
MH175
score
determined
be
≥
3
points,
resulting
sensitivity
96.1%,
specificity
63.4%,
positive
58%,
negative
96.9%.
Conclusions
robust
capacity
COVID-19.
Implementation
settings
can
aid
stratification
facilitate
application
strategies,
ultimately
reducing
death.
Therefore,
utilization
holds
potential
improve
Trial
registration
An
ethics
committee
approved
(Research
Ethics
Committee
(No.
3598GCN-HDDD;
date:
8,
2021),
which
performed
accordance
Declaration
Helsinki,
Guidelines
Good
Clinical
Practice.
There
is
still
limited
research
on
the
prognostic
value
of
Presepsin
as
a
biomarker
for
predicting
outcome
COVID-19
patients.
Additionally,
combined
predictive
with
clinical
scoring
systems
and
inflammation
markers
disease
prognosis
lacking.
Journal of Inflammation Research,
Год журнала:
2024,
Номер
Volume 17, С. 3879 - 3891
Опубликована: Июнь 1, 2024
Background:
Research
on
biomarkers
associated
with
the
severity
and
adverse
prognosis
of
COVID-19
can
be
beneficial
for
improving
patient
outcomes.
However,
there
is
limited
research
role
soluble
TREM-1
(sTREM-1)
in
predicting
patients.
Methods:
A
total
115
patients
admitted
to
emergency
department
Beijing
Youan
Hospital
from
February
May
2023
were
included
study.
Demographic
information,
laboratory
measurements,
blood
samples
sTREM-1
levels
collected
upon
admission.
Results:
Our
study
found
that
plasma
increased
disease
(moderate
vs
mild,
p=0.0013;
severe
moderate,
p=0.0195).
had
good
predictive
value
28-day
mortality
(area
under
ROC
curve
was
0.762
0.805,
respectively).
also
exhibited
significant
correlations
age,
body
temperature,
respiratory
rate,
PaO
2
/FiO
,
PCT,
CRP,
CAR.
Ultimately,
through
multivariate
logistic
regression
analysis,
we
determined
(OR
1.008,
95%
CI:
1.002–
1.013,
p=0.005),
HGB
0.966,
0.935–
0.998,
p=0.036),
D-dimer
1.001,
1.000–
p=0.009),
CAR
1.761,
1.154–
2.688,
p=0.009)
independent
predictors
The
combination
these
four
markers
yielded
a
strong
cases
an
AUC
0.919
(95%
0.857
−
0.981).
Conclusion:
demonstrated
mortality,
serving
as
prognostic
factor
In
future,
anticipate
conducting
large-scale
multicenter
studies
validate
our
findings.
Keywords:
COVID-19,
sTREM-1,
inflammation-related
markers,
severity,
Briefings in Bioinformatics,
Год журнала:
2025,
Номер
26(2)
Опубликована: Март 1, 2025
Survival
prediction
serves
as
a
pivotal
component
in
precision
oncology,
enabling
the
optimization
of
treatment
strategies
through
mortality
risk
assessment.
While
integration
histopathological
images
and
genomic
profiles
offers
enhanced
potential
for
patient
stratification,
existing
methodologies
are
constrained
by
two
fundamental
limitations:
(i)
insufficient
attention
to
fine-grained
local
features
favor
global
representations,
(ii)
suboptimal
cross-modal
fusion
that
either
neglect
intrinsic
correlations
or
discard
modality-specific
information.
To
address
these
challenges,
we
propose
DSCASurv,
novel
alignment
framework
designed
explore
integrate
across
multimodal
data,
thereby
improving
accuracy
survival
prediction.
Specifically,
DSCASurv
leverages
feature
extraction
capabilities
convolutional
layers
long-range
dependency
modeling
scanning
state
space
models
extract
intra-modal
while
generating
representations
dual
parallel
mixer
architectures.
A
module
functions
bridge
inter-modal
information
exchange
complementary
transfer.
The
ultimately
integrates
all
generate
predictions
enhancing
recalibrating
Extensive
experiments
on
five
benchmark
cancer
datasets
demonstrate
superior
performance
our
approach
compared
methods.
Archives of Public Health,
Год журнала:
2025,
Номер
83(1)
Опубликована: Март 24, 2025
Abstract
Background
The
COVID-19
pandemic
disproportionately
affected
vulnerable
populations
in
terms
of
comorbidity
and
socioeconomic
disadvantage,
both
between
within
countries.
This
retrospective
population-based
cohort
study
is
part
the
Horizon
2020
ORCHESTRA
project,
was
conducted
Emilia-Romagna
(E-R)
Region,
aimed
to
investigate
risk
hospitalization,
disease
severity
all-cause
mortality
during
30
days
following
SARS-CoV-2
infection.
Methods
All
adult
positive
cases
notified
E-R
from
2022
were
included.
Poisson
regression
with
robust
standard
error
used
estimate
ratios
for
three
outcomes,
stratified
by
sex,
period
adjusted
age,
citizenship,
deprivation
index,
hospitalization
death
score
(RHDS),
vaccination
status.
Data
sources
regional
healthcare
databases.
Supplementary
analyses
considered
citizenship
relation
duration
residency
or
aggregated
areas
origin.
Results
During
first
two
years
859,653
residents
tested
(47.8%
males);
9.6%
them
citizens
high
migratory
pressure
countries
(HMPCs).
severe
outcomes
increased
steeply
especially
males.
RHDS
predicted
worse
sexes
while
showed
a
strong
protective
effect
against
all
acute
infection
(i.e.,
recent
85%
more
in-hospital
sexes).
Immigrants
HPMCs,
females,
higher
disease,
particular
those
who
arrived
5
ago
(RR
=
1.92,
95%CI
1.76-2.00
males,
RR
2.40,
2.23–2.59
females),
whereas
lower
compared
low
(LMPCs)
that
females
0.73
(95%CI
0.59–0.90).
Conclusions
results
provided
an
overall
view
course
allowed
associated
clinical,
demographic,
social
characteristics
be
measured.
findings
suggest
that,
although
national
public
health
policies
have
helped
mitigate
impact
general
population,
inequalities
among
persons
comorbidities
disadvantages
remain.
Improvements
appropriateness,
effectiveness
equity
strategies
are
needed.
Biomedicines,
Год журнала:
2025,
Номер
13(5), С. 1025 - 1025
Опубликована: Апрель 24, 2025
Background:
Artificial
intelligence
tools
can
help
improve
the
clinical
management
of
patients
with
severe
COVID-19.
The
aim
this
study
was
to
validate
a
machine
learning
model
predict
admission
Intensive
Care
Unit
(ICU)
in
individuals
Methods:
A
total
201
hospitalized
COVID-19
were
included.
Sociodemographic
and
data
as
well
laboratory
biomarker
results
obtained
from
medical
records
information
system.
Three
models
generated,
trained,
internally
validated:
logistic
regression
(LR),
random
forest
(RF),
extreme
gradient
boosting
(XGBoost).
evaluated
for
sensitivity
(Sn),
specificity
(Sp),
area
under
curve
(AUC),
precision
(P),
SHapley
Additive
exPlanation
(SHAP)
values,
utility
predictive
using
decision
analysis
(DCA).
Results:
included
following
variables:
type
2
diabetes
mellitus
(T2DM),
obesity,
absolute
neutrophil
basophil
counts,
neutrophil-to-lymphocyte
ratio
(NLR),
D-dimer
levels
on
day
hospital
admission.
LR
showed
an
Sn
0.67,
Sp
0.65,
AUC
0.74,
P
0.66.
RF
achieved
0.87,
0.83,
0.96,
0.85.
XGBoost
demonstrated
0.85,
0.95,
0.86.
Conclusions:
Among
models,
robust
performance
(Sn
=
0.86)
favorable
net
benefit
analysis,
confirming
its
suitability
predicting
ICU
aiding
decision-making.